Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Retinal Diseases
Lessons Learned from Recent Clinical Trials on DR
Open-Label Extension of RIDE and RISE Shows Improved Visual Outcomes Maintained without Ranibizumab Retreatment
Diabetes Practice Update: Diabetic Peripheral Neuropathy, Retinopathy, and Chronic Kidney Disease
Novel Pharmacotherapies in the Treatment of Diabetic Retinopathy
Diabetic Retinopathy and Coronary Heart Disease
Diabetic Retinopathy: Changing Prevalence and Severity Require Flexible Interventions
Intraocular Use of Anti-VEGF Antibody Fragment Improves Vision and Retinal Anatomy in DR
Diabetic Retinopathy and the ACCORD Trial
Candesartan Slows the Onset of Retinopathy in Patients with Type 1 Diabetes
Candesartan Reverses Retinopathy in Type 2 Diabetes
Pages
Next
1
2